2 withdrawn, 1 completed, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Withdrawn 2, Completed 1, Unknown 1 |
Follow HCV: new trials by email Literature Review of HCV trials Research Report on HCV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease. Ledipasvir/Sofosbuvir - Gaucher Disease, HCV | Phase 4 | Unknown | Mansoura University Children Hospital | 10 | 2018-04-03 | 2018-10-30 |
| Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet sofosbuvir/velpatasvir tablet, sofosbuvir/velpatasvir crushed - HCV | Phase 4 | Withdrawn | Radboud University Medical Center | 2018-04-01 | 2020-12-07 | |
| A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A elbasvir/grazoprevir, Sofosbuvir, Ribavirin - HCV | Phase 4 | Withdrawn | Fundacion SEIMC-GESIDA | 2017-07-01 | 2018-06-08 | |
| Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV Sofosbuvir-Simeprevir, Sofosbuvir-Ribavirin - HCV | Phase 4 | Completed | Ain Shams University | 90 | 2015-06-01 | 2017-03-03 |
Gaucher Disease (1) · Pressure Ulcer (1)
Brain Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Lipid Metabolism Disorders (1) · Lipid Metabolism, Inborn Errors (1) · Lipidoses (1) · Lysosomal Storage Diseases (1) · Lysosomal Storage Diseases, Nervous System (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nervous System Diseases (1) · Nutritional and Metabolic Diseases (1)
Sofosbuvir (2) · Ribavirin (1) · elbasvir-grazoprevir drug combination (1) · ledipasvir, sofosbuvir drug combination (1) · sofosbuvir-velpatasvir drug combination (1)
Ain Shams University (1) · Fundacion SEIMC-GESIDA (1) · Mansoura University Children Hospital (1) · Radboud University Medical Center (1)
Egypt (1) · Germany (1) · Netherlands (1) · Spain (1)